S734 Etrasimod 2mg Once Daily as Treatment for Patients With Moderately to Severely Active Ulcerative Colitis: Topline and Subgroup Analysis From ELEVATE UC 52 and ELEVATE UC 12. (October 2022)

• Record Type: Journal Article
• Authors: Peyrin-Biroulet, Laurent; Sandborn, William J.; D'Haens, Geert; Panés, Julian; Yarur, Andres; Wolf, Douglas C.; Ritter, Timothy E.; Schreiber, Stefan; Sloan, Sheldon; Cataldi, Fabio; Shan, Kevin; Rabbat, Christopher J.; Chiorean, Michael; Baert, Filip; Sands, Bruce E.; Dubinsky, Marla C.; Vermeire, Séverine; Goetsch, Martina; Danese, Silvio
• Other Names: Feagan Brian G. presenter.
• Is Part Of: American journal of gastroenterology. Volume 117:Number 10(2022)supplement 10S
• Page Start: e516
• Page End: e517
• Publication Date: 2022-10
• Subjects: Stomach -- Diseases -- Periodicals; Intestines -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Gastrointestinal Diseases -- Periodicals; Electronic journals; Periodicals; 616.33
• DOI: 10.14309/01.ajg.0000859576.23012.a3
• Languages: English
• ISSNs: 0002-9270